For: | Michaelidou M, Pappachan JM, Jeeyavudeen MS. Management of diabesity: Current concepts. World J Diabetes 2023; 14(4): 396-411 [PMID: 37122433 DOI: 10.4239/wjd.v14.i4.396] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i4/396.htm |
Number | Citing Articles |
1 |
Anjaneyulu Kowluru. Regulatory roles of CARD9-BCL10-Rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for MALT1?. Biochemical Pharmacology 2023; 218: 115889 doi: 10.1016/j.bcp.2023.115889
|
2 |
Fanny Petermann‐Rocha, Evelia Apolinar, Gabriela Nazar, Felipe Diaz‐Toro, Andrés Celis, Salil Deo, Gerson Ferrari, Gary O'Donovan. Associations of diabesity with all‐cause and cardiovascular disease mortality: Findings from the Mexico City Prospective Study. Diabetes, Obesity and Metabolism 2024; doi: 10.1111/dom.15528
|
3 |
Waleed Albaker, Mohammed Al-Hariri. Metabolic surgery in patients with diabesity: A review of the historical backgrounds and scoring systems. Electronic Journal of General Medicine 2024; 21(1): em564 doi: 10.29333/ejgm/14093
|
4 |
Stjepan Eržen, Gašper Tonin, Dubravka Jurišić Eržen, Jasna Klen. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences 2024; 25(3): 1517 doi: 10.3390/ijms25031517
|
5 |
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, Dania Blaibel, Vishnu Chandrabalan, Joseph M Pappachan. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience. World Journal of Diabetes 2024; 15(3): 463-474 doi: 10.4239/wjd.v15.i3.463
Abstract(100) |
Core Tip(84) |
Full Article(HTML)(697)
|
Full Article with Cover (PDF)-1271K(60)
|
Full Article (Word)-381K(0)
|
Audio-1428K(3)
|
Peer-Review Report-175K(13)
|
Answering Reviewers-179K(11)
|
Full Article (PDF)-893K(94)
|
Full Article (XML)-122K(11)
|
Times Cited (0)
|
Total Visits (1733)
|
Open
|
6 |
Xian Yang, Xudong Li, Manjiang Hu, Jie Huang, Siyan Yu, Huanting Zeng, Limei Mao. EPA and DHA Differentially Improve Insulin Resistance by Reducing Adipose Tissue Inflammation — Targeting GPR120/PPARγ Pathway. The Journal of Nutritional Biochemistry 2024; : 109648 doi: 10.1016/j.jnutbio.2024.109648
|
7 |
Weiling Tu, Liang Li, Ming Yi, Junyu Chen, Xiaoqing Wang, Yan Sun. Dapagliflozin attenuates high glucose-and hypoxia/reoxygenation-induced injury via activating AMPK/mTOR-OPA1-mediated mitochondrial autophagy in H9c2 cardiomyocytes. Archives of Physiology and Biochemistry 2023; : 1 doi: 10.1080/13813455.2023.2252200
|
8 |
Szymon Suwała, Aleksandra Białczyk, Kinga Koperska, Alicja Rajewska, Magdalena Krintus, Roman Junik. Prevalence and Crucial Parameters in Diabesity-Related Liver Fibrosis: A Preliminary Study. Journal of Clinical Medicine 2023; 12(24): 7760 doi: 10.3390/jcm12247760
|
9 |
Stephanie W. Waldrop, Veronica R. Johnson, Fatima Cody Stanford. Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity. Nature Medicine 2024; 30(1): 22 doi: 10.1038/s41591-023-02669-x
|
10 |
Eleni Pavlidou, Sousana K. Papadopoulou, Aristeidis Fasoulas, Vasileios Papaliagkas, Olga Alexatou, Maria Chatzidimitriou, Maria Mentzelou, Constantinos Giaginis. Diabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management. Nutrients 2023; 16(1): 34 doi: 10.3390/nu16010034
|
11 |
Matthew Darok, Alexander Daly, Vonn Walter, Conrad Krawiec. Association of medical comorbidities in obese subjects diagnosed with heparin-induced thrombocytopenia. SAGE Open Medicine 2024; 12 doi: 10.1177/20503121241247471
|
12 |
Muhammad Daoud Butt, Siew Chin Ong, Azra Rafiq, Tooba Malik, Ahsan Sajjad, Nighat Batool, Anwaar Ul Hassan Chughtai, Muhammad Umar Wahab, Muhammad Abdullah, Zaheer-Ud-Din Babar. An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-50517-2
|